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Creation and disruption of protein features by alternative splicing <p>A new mechanism of alternative splicing is proposed which creates a protein feature by putting together two non-consecutive exons  and destroys a feature by inserting an exon in its body. Evidence for this rare mechanism is provided by a genome-wide search with four  specific protein features.</p>
Abstract
Background: Alternative splicing often occurs in the coding sequence and alters protein structure
and function. It is mainly carried out in two ways: by skipping exons that encode a certain protein
feature and by introducing a frameshift that changes the downstream protein sequence. These
mechanisms are widespread and well investigated.
Results: Here, we propose an additional mechanism of alternative splicing to modulate protein
function. This mechanism creates a protein feature by putting together two non-consecutive exons
or destroys a feature by inserting an exon in its body. In contrast to other mechanisms, the
individual parts of the feature are present in both splice variants but the feature is only functional
in the splice form where both parts are merged. We provide evidence for this mechanism by
performing a genome-wide search with four protein features: transmembrane helices,
phosphorylation and glycosylation sites, and Pfam domains.
Conclusion: We describe a novel type of event that creates or removes a protein feature by
alternative splicing. Current data suggest that these events are rare. Besides the four features
investigated here, this mechanism is conceivable for many other protein features, especially for
small linear protein motifs. It is important for the characterization of functional differences of two
splice forms and should be considered in genome-wide annotation efforts. Furthermore, it offers a
novel strategy for ab initio prediction of alternative splice events.
Background
Alternative splicing is an important post-transcriptional
process and mainly contributes to the complexity of a tran-
scriptome and proteome [1-3]. Alternative splicing often pro-
duces two or more proteins with functional differences from
one gene [4] but can also downregulate the overall protein
level by producing targets for nonsense-mediated mRNA
decay [5], which is used, for example, in the autoregulation of
splicing factors [6]. Furthermore, defects in splicing are the
basis for a number of diseases [7].
One major mechanism of alternative splicing to alter protein
function is the insertion/deletion of functional units such as
protein domains, transmembrane (TM) helices, signal pep-
tides, or coiled-coil regions. Alternative splicing tends to
insert/delete complete functional units instead of affecting
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parts of a unit [8]. Moreover, several protein domains have a
tendency to be spliced out in some transcripts [9,10]. Many
proteins occur in a soluble as well as a membrane-bound
form. When encoded by a single gene, the soluble form can be
produced by post-translational ectodomain shedding [11] or
alternative splicing of exons that encode the TM helices.
Indeed, 40-50% of the alternatively spliced, single-pass TM
proteins have a splice form that specifically removes the TM
domain [12,13]. Furthermore, protein forms can differ in
their affinity to bind ligands [14,15] or in their subcellular
location [16].
In this paper, we present a novel mechanism to modulate
function and/or subcellular localization of a protein by alter-
native splicing. Assuming a protein feature is encoded in two
parts by two non-consecutive exons, for example, exon 2 and
4, inclusion of exon 3 results in a protein lacking this feature
since it is disconnected at the sequence level. In contrast, the
skipping of exon 3 leads to a protein with this feature. We pro-
vide evidence for this mechanism by considering four protein
features: TM helices, phosphorylation and glycosylation sites,
and Pfam domains. In general, this mechanism is conceivable
for many other protein features and provides a novel strategy
for ab initio prediction of alternative splice events.
Results and discussion
In order to find genes that encode a protein feature by two
non-consecutive exons, we searched all human RefSeq tran-
scripts for annotated features that span an exon boundary.
For these exon pairs, we searched dbEST to find alternative
splice events that insert a sequence between them. Thus, we
only selected pairs of exons if they had expressed sequence
tag (EST)-confirmed, alternative exons between them that
are skipped in the given RefSeq. Apart from alternative exons,
intron retention or an alternative donor/acceptor site located
in the intron can lead to such an insert. We only selected
inserts that preserved the open reading frame. Then we eval-
uated whether the longer transcript (with the insert) still
encodes the feature or not. We only considered two exons for
small features like TM helices and post-translational modifi-
cation contexts since it is unlikely that more than two exons
encode the feature. For more complex features like Pfam
domains, we allowed for the domain to be encoded by more
than two exons.
The first protein feature we considered was TM domains. We
annotated TM helices in all RefSeq transcripts with the
TMHMM program [17]. We found 1,807 TM domains (14% of
all TM domains) that are encoded by two exons (Additional
data file 1). For ten cases, we found EST evidence for an insert
due to alternative splicing. As TM domains are short stretches
of hydrophobic amino acids, an insert with polar residues will
result in the destruction of the TM helix. Indeed, the evalua-
tion of these ten longer transcripts with TMHMM showed
that six clearly lacked the TM domain which, in three cases,
leads to a soluble protein (Table 1). An example of the disrup-
tion of the single TM domain is depicted for DIABLO in Fig-
ure 1a. A more complex example is at the Rhesus blood group
antigen gene (RHCE) where the inclusion of two exons
resulted in a loss of one TM domain as well as the gain of three
others (Figure 1b). The massive reconstruction of TM
domains in the respective protein isoforms can have consid-
erable consequences for the orientation of the proteins within
the cellular membrane and for their interaction with other
membrane components.
Additional File 1 (TM domains that are encoded by two exons) TM domains that are  encoded by two exons Click here for file To find further cases of feature disruption by sequence inser-
tion, we applied the procedure to experimentally verified
post-translational modification sites. Post-translational mod-
ification of proteins plays a role in various important proc-
esses. For example, phosphorylation of splicing factors can
influence splicing decisions [18] and glycosylation is associ-
ated with a modulation of proteolytic resistance and ligand
binding [19]. The residue to be modified must be located in a
favorable sequence context to be recognized by the enzyme. If
this residue is close to an exon boundary, an alternative splice
event can change the context to an unfavorable one with the
consequence that the modification cannot take place any-
more. We inspected the O-GlycBase [19] and Phospho.ELM
[20], and found 435 modified residues that are close to 213
different exon-exon junctions. Among them, four exon junc-
tions showed an insert due to alternative splicing. CCL14 has
a glycosylated serine at position 26, which is the last residue
encoded by exon 1. We found two ESTs (AA612866, Z70293)
with an included 48-nucleotide exon between exon 1 and 2.
The NetOGlyc [21] score for the serine in the new sequence
context dropped from 0.97 to 0.35 (threshold 0.5). Thus, the
new context might prevent glycosylation of this residue. For
CDK5, an alternative acceptor (BU529114) that inserts nine
amino acids upstream of exon 8 alters the context of the phos-
phorylated serine at position 159 of the protein. The NetPhos
[22] scores of both contexts differ (0.93 vs 0.43, threshold
0.5), which indicates that only one context allows recognition
by the kinase and, thus, the phosphorylation of the serine.
Additionally, we found two examples (MGP and CDK2) where
an included exon alters the context of a phosphorylated resi-
due, however, the scores for the new contexts dropped only
marginally.
For the fourth feature, we considered functional protein
domains using the Pfam database [23]. We found 473 inserts
into a Pfam domain and nine of those resulted in a disruption
of the Pfam (Table 2). Additionally, using the algorithm
described in [24], we found three cases where the skipping of
a RefSeq exon creates a new Pfam (Table 2). For example,
skipping exon 4 of NM_024565 created the cyclin N-terminal
domain (Figure 2a). Since exons 5 to 7 of this transcript
encode the cyclin C-terminal domain (PF02984), only the
exon skipping variant might perform the function of a cyclin.
Moreover, skipping exon 2 of NM_139174 resulted in a new
double-stranded RNA binding domain (Figure 2b).http://genomebiology.com/2005/6/7/R58 Genome Biology 2005,     Volume 6, Issue 7, Article R58       Hiller et al. R58.3
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Genome Biology 2005, 6:R58
Downstream of this domain, the transcript encodes an adeno-
sine-deaminase (editase) domain. Thus, the loss of the RNA
binding property might act as a negative regulation of the edi-
tase activity. Most Pfam domains fold into three-dimensional
structures and we cannot rule out that these 12 domains also
adopt the correct folding with the insert. However, using
standard cut-off scores, these Pfam domains cannot be found
in the longer transcripts since the scores for both individual
parts are always below the threshold.
In general, any EST-based approach is hampered by the bias
of publicly available EST databases towards cancer-related
tissues or cell lines that may exhibit aberrant splicing [25,26].
Furthermore, a splice form that is only represented by a single
EST may be a rare error by the spliceosome. Therefore, we
determined the number and tissue source of the ESTs that
match both splice variants for the described examples (Addi-
tional data file 2). For seven of the 20 examples, only one
s p l i c e  f o r m  i s  r e p r e s e n t e d  b y  a  s i n g l e  E S T  o r  b y  c a n c e r -
related ESTs. However, the remaining examples are sup-
ported by several ESTs as well as ESTs from normal tissue,
TM domain destruction by exon insertion Figure 1
TM domain destruction by exon insertion. (a) Exons 2 and 3 of NM_138929 of DIABLO encode a TM domain (shown as blue boxes). This TM domain is 
destroyed in another transcript (NM_019887) that includes an additional exon. The inserted exon (shown in red) encodes many polar amino acids. (b) 
Exons 3 and 4 of NM_138617 of RHCE encode a TM domain that is destroyed in NM_138618 by the inclusion of two exons. Interestingly, the two 
included exons encode three new TM domains. Thus, the skipping of exon 4 and 5 of NM_138618 results in a protein that has only two instead of three 
TM domains fewer. Exon numbers refer to the respective transcript. TM, transmembrane.
Table 1
RefSeq transcripts where, due to alternative splicing, sequence insertion destroys a TM helix
Gene symbol Gene name RefSeq with TM* RefSeq/EST without TM† Alternative splice event‡ Impact
DIABLO Diablo homolog (Drosophila) NM_138929 NM_019887 Exon between exon 2 and 3 Disruption of the single TM domain, 
soluble protein
DPP8 Dipeptidylpeptidase 8 NM_017743 NM_197961 Exon between exon 15 and 16 Disruption of the single TM domain, 
soluble protein
COX7A2 Cytochrome c oxidase subunit VIIa 
polypeptide 2 (liver)
NM_001865 BU570379 Donor downstream of exon 3 Disruption of the single TM domain, 
soluble protein
RHCE Rhesus blood group, CcEe antigens NM_138617 NM_138618 Two exons between exon 3 and 4 Disruption of the fifth TM domain, 
insert contains three new TM 
domains
na na NM_014738 BM693684 Intron between exon 30 and 31 Disruption of the eighth TM domain
na na NM_152672 CF147426 Acceptor upstream of exon 4 Disruption of the second TM 
domain
*RefSeq transcript without the insert (shorter variant) that encodes a TM domain. †Transcript with the insert (longer variant) that destroys a TM 
helix. ‡Exon numbers refer to the RefSeq transcript with the TM helix. na, not approved; TM, transmembrane.
NM_019887
AVYTLTSLY...
KSEP...EYTK ...IGFGVTLCAVPIAQ AVYTLTSLY...
...IGFGVTLCAVPIAQ
exon 2
exon 2
exon 3 
exon 4 
NM_138929
(a)
RHCE (b)
TYVHSAVLAGGVAVG... TDY...
TYVHSAVLAGGVAVG...
NM_138618
...MVISNIFN
...MVISNIFN ...ISM
exon 3 
exon 4 
exon 6 
NM_138617 exon 3 
DIABLOR58.4 Genome Biology 2005,     Volume 6, Issue 7, Article R58       Hiller et al. http://genomebiology.com/2005/6/7/R58
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and in four cases both splice variants are contained in the Ref-
Seq database. Thus, we conclude that the majority of the
described examples are real splice variants and not artifacts
or aberrant splice events.
Additional File 2 (ESTs/RefSeqs and if available their tissue/library source for the  described example) ESTs/RefSeqs and if available their tissue/ library source for the described examples Click here for file Besides the four features investigated here, there are many
others that can only function if they are connected on the
sequence level. Such functional sites or motifs often have a
linear structure and comprise, for example, signal peptides,
post-translational cleavage sites and subcellular localization
signals as well as sites for protein-protein interaction. Many
of these motifs are collected in the Eukaryotic Linear Motif
(ELM) database [27]. Such features can lose their function if
an insert separates them on the sequence level. For example,
splicing at an alternative donor site of the protein kinase C
delta leads to an insert of 26 amino acids into a caspase-3
cleavage site and to an isoform that is caspase-insensitive
[28]. We have not investigated such features here since only a
fraction of them have been experimentally verified and a pre-
diction results in a high number of false positives. With fur-
ther efforts in verifying and characterizing these features, we
expect an increasing number of examples for the proposed
mechanism of modulating protein function by alternative
splicing. Interestingly, the same principle was recently used
to experimentally characterize exon splicing silencers (ESS)
[29]. In this study, ESS candidates were inserted in the mid-
dle exon of a three-exon minigene. If a candidate ESS acts as
a silencer, the middle exon is skipped and only in this case a
functional green fluorescent protein is encoded. Further-
more, this mechanism is not restricted to protein features but
it is also conceivable for sequence and structural features at
the mRNA level. For example, some of the variable first exons
of NOS1 together with exon 2, form a hairpin structure that is
involved in translational regulation, whereas other alterna-
tive first exons do not allow hairpin formation [30].
From an evolutionary viewpoint, this mechanism can be
explained in two ways depending on whether the protein fea-
ture is ancestral or not. If the feature is ancestral, it means it
is initially encoded by two neighboring exons and the inserted
Table 2
RefSeq transcripts with an exon skipping splice form that puts together a new Pfam domain
Gene symbol Gene name RefSeq/EST 
with Pfam*
RefSeq/EST 
without Pfam†
Pfam ID Pfam description Alternative 
splice event‡
Pfam cutoff 
score§
Score 
upstream¶
Score 
downstream¥
Score 
combined#
na na NM_144604 AK056632 PF00642 Zinc finger C-x8-
C-x5-C-x3-H type 
(and similar)
Exon between 
exon 3 and 4
17.5 -1.2 9.4 23.6
PRSS25 protease, serine, 25 NM_145074 AF141306 PF00089 Trypsin Acceptor 
upstream of 
exon 4
23.4 3.0 1.1 30.8
FOSL2 FOS-like antigen 2 NM_005253 BX647822 PF00170 bZIP transcription 
factor
Acceptor 
upstream of 
exon 4
23.2 16.1 -4.6 31.3
na na NM_003622 AB033056 PF02920 Integrase_DNA Exon between 
exon 8 and 9
18.0 13.4 -5.0 21.9
na na NM_006832 AK091532 PF00373 FERM domain 
(Band 4.1 family)
Exon between 
exon 12 and 13
14.0 -15.9 10.3 15.6
PQBP1 Polyglutamine 
binding protein 1
NM_144494 BM692479 PF00397 WW domain Acceptor 
upstream of 
exon 3
17.0 5.0 9.7 32.5
MRPL27 Mitochondrial 
ribosomal protein 
L27
NM_148570 BQ028639 PF01016 Ribosomal L27 
protein
Acceptor 
upstream of 
exon 4
25.0 2.1 8.2 34.0
PLEKHB1 Pleckstrin homology 
domain containing, 
family B (evectins) 
member 1
NM_021200 BE703269 PF00169 PH domain Acceptor 
upstream of 
exon 3
22.8 -3.3 11.4 29.7
na na NM_020679 BP265352 PF02854 MIF4G domain Donor 
downstream of 
exon 6
14.0 1.1 0.2 17.2
TRUB2 TruB pseudouridine 
(psi) synthase 
homolog 2 (E. coli)
BE793897 NM_015679 PF00849 RNA 
pseudouridylate 
synthase
Skip exon 2 14.0 -2.1 -1.3 14.7
na na BM903757 NM_024565 PF00134 Cyclin, N-terminal 
domain
Skip exon 4 17.0 0.3 9.6 52.9
na na BC033491 NM_139174 PF00035 Double-stranded 
RNA binding motif
Skip exon 2 17.0 -5.2 13.5 21.7
*Transcript without the insert (shorter variant) that encodes a Pfam domain. †Transcript with the insert (longer variant) that does not encode a Pfam 
domain. ‡Exon numbers refer to the RefSeq transcript. §Per-domain 'gathering cut-offs' as given in the Pfam database. ¶,¥Pfam score for the partial 
domain encoded by the upstream and downstream exon, respectively. #Pfam score for the domain that is encoded by the splice form without the 
insert. na, not approved.http://genomebiology.com/2005/6/7/R58 Genome Biology 2005,     Volume 6, Issue 7, Article R58       Hiller et al. R58.5
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part must have appeared in the intronic sequences [31-33]. In
this case, the insert simply has the function of a spacer. If the
feature is not ancestral, it means the longer splice form is evo-
lutionarily older and, therefore, the alternative exon or splice
site must have been converted from a constitutive to an alter-
native one. This can happen, for example, by the weakening of
Pfam creation by exon skipping Figure 2
Pfam creation by exon skipping. The alternative exon is shown in red. The two partial Pfam alignments for the RefSeq transcript and the complete 
alignment for the exon-skipping variant are shown above and below the partial gene structure, respectively. Dashed lines indicate parts of the exon for 
which a Pfam alignment has been found. (a) NM_024585 has a splice form that skips exon 4 (shown in red), which results in the creation of a new domain. 
The Pfam scores for the separated parts are far below the threshold score of 17 and, thus, the Pfam is not found for the longer transcript. (b) Skipping 
exon 2 of NM_139174 results in a new double-stranded RNA binding Pfam.
FtvevkvggktyvrktfgeGsGsSKKeAkqaAAeaALrkL
F v ++++g +      + G++ SK eAkq+AA +AL ++
FSVSAELDGVV-----CPAGTANSKTEAKQQAALSALCYI
AeaALrkL
A++A++ L
AARAWENL
pksaLqelaqkrklplpeYelvkeeGptPahaprFtvevkvggktyvrktfgeGsGsSKKeAkqaAAeaALrkL
++s+L e+a      l  + l +e++p P+ +  F v ++++g +      + G++ SK eAkq+AA +AL ++
AVSLLTEYAAS----LGIFLLFREDQP-PGPCFPFSVSAELDGVV-----CPAGTANSKTEAKQQAALSALCYI
exon 1 exon 3  exon 2 
Pfam score: 5.2 Pfam score: 13.5
Pfam score: 21.7
yLavnylDRFLskkkfpklkvkrkklQLvgvtclfiAsKyEEiksdvypPsvkdf..vyitasDnqaytkkeilrMEkliLktLkfdls
+Lav++lD F+ ++++    ++ k+l  v+v+cl++AsK+E+ ++  ++P++++ ++ +i +s n + tkke+l  E+l+L++  ++l+
HLAVYLLDHFMDRYNV----TTSKQLYTVAVSCLLLASKFEDRED--HVPKLEQInsTRILSSQNFTLTKKELLSTELLLLEAFSWNLC
exon 3 exon 5  exon  4
lDRFLskkkfpklkvkrkklQLvgvtclfiA
+DR+   + +    ++ k+l  v+v+cl++A
MDRY---N-V----TTSKQLYTVAVSCLLLA
aytkkeilrMEkliLktLkfdls
+ tkke+l  E+l+L++  ++l+
TLTKKELLSTELLLLEAFSWNLC
(b)
NM_139174
protein sequence
Pfam consensus
Pfam consensus
protein sequence
Double-stranded RNA binding motif (PF00035)
protein sequence
Pfam consensus
Pfam consensus
protein sequence
Pfam score: 9.6 Pfam score: 0.3
threshold score: 17
NM_024565
Cyclin, N-terminal domain (PF00134)    
threshold score: 17
(a)
Pfam score: 52.9R58.6 Genome Biology 2005,     Volume 6, Issue 7, Article R58       Hiller et al. http://genomebiology.com/2005/6/7/R58
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splice sites or the creation of ESS [34]. Complex features with
a high sequence specificity such as Pfam domains are likely to
be ancestral. In contrast, small features with a loose sequence
motif such as the context of a post-translational modification
site can arise just by chance and can therefore be evolutionar-
ily younger.
Not all alternative splice events are represented in EST data-
bases and, thus, the development of non-EST-based methods
for ab initio prediction of splice events is a necessary but chal-
lenging task. Currently, there is only one method that mainly
uses genomic conservation of exons and flanking introns to
discriminate between alternative and constitutive exons [35].
Although alternative splicing often deletes functional units, it
is very hard to predict such events on the protein level without
ESTs. However, a search for protein features that are put
together by exon skipping would provide a new way to predict
alternative splice events. For that purpose, it has to be
assumed that the split feature is unlikely to be encoded by two
non-consecutive exons just by chance. Since Pfam domains
usually have a high sequence specificity, we tested this
assumption for Pfams by skipping 10,962 constitutive exons.
We found only four cases (0.036%) where skipping of a con-
stitutive exon results in an additional Pfam domain (Addi-
tional data file 3). In contrast, nine of the 473 (1.9%)
alternatively spliced inserts into Pfam domains resulted in a
loss of the Pfam. The odds ratio of 53 indicates that Pfam
domains are unlikely to be encoded by non-consecutive exons
just by chance.
Additional File 3 (Pfam creation events by skipping of a constitutive exon) Pfam cre- ation events by skipping of a constitutive exon Click here for file
Conclusion
Alternative splicing frequently modulates protein function by
insertion or deletion of functional units. In this case, the func-
tional difference is directly associated with the sequence of
the inserted or deleted part. Here, we provide evidence for an
additional mechanism that acts by putting together a feature
from two parts encoded by non-consecutive exons. Thus, the
functional difference is not related to a specific insert and the
two parts of the feature are present on both the long and the
short splice form. The general idea is shown in Figure 3.
Recent alternative splicing databases include the annotation
of the functional differences between two protein forms [36].
For this purpose, the novel mechanism described here has to
be taken into account since it is obviously not sufficient to
inspect the alternative exons in the context of the splice form
that includes these exons. The functional difference of the
examples shown here can only be found if the complete
shorter splice form is investigated simultaneously.
Materials and methods
General procedure
All transcripts were taken from the RefSeq annotations in the
UCSC Genome Browser (assembly hg16 with annotation
March 2004) [37]. For exon pairs that together encode a pro-
tein feature, we extracted a 40-nucleotide context (20 nucle-
otides from the upstream and 20 nucleotides from the
downstream exon) and searched, with BLAST, the human
fraction of dbEST (August 2004) [38]. We only kept EST hits
with two separate HSPs (high-scoring segment pairs).We
discarded splice events that resulted in a frameshift and/or
introduced a premature termination codon (PTC) since a
frameshift leads to a new protein sequence downstream of the
alternative splice site and transcripts with PTCs are fre-
quently degraded by nonsense-mediated mRNA decay.
Intron retention events were only included if the EST had a
spliced intron up- or downstream. For the insertions, we
checked presence of AG-GT splice sites. All splice forms were
General mechanisms to alter linear protein features by alternative splicing Figure 3
General mechanisms to alter linear protein features by alternative splicing. 
(a) A widespread mechanism is to skip or include an alternative exon (red 
box) that encodes a functional unit (indicated by the light bulb). The longer 
splice form with the alternative exon encodes a protein with this feature, 
the shorter splice form encodes a protein without this feature. (b) The 
novel mechanism involves a functional unit that is encoded by two non-
consecutive exons (the two parts of the light bulb). In contrast to the 
mechanism mentioned above, the longer splice form encodes a protein 
without the functional unit although both parts are present on the protein 
sequence. The disruption of the unit results in a loss of function. The 
shorter splice form encodes a protein that puts together both parts of the 
unit which results in a gain of function (complete light bulb).
(a)
protein without
functional unit
protein with
functional unit
protein without
functional unit
protein with
functional unit
two splice forms
gene
gene
two splice forms
(b)http://genomebiology.com/2005/6/7/R58 Genome Biology 2005,     Volume 6, Issue 7, Article R58       Hiller et al. R58.7
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Genome Biology 2005, 6:R58
translated with the insertion and a check was made to see if
the insert destroyed the feature.
TM domains
We predicted TM helices with TMHMM for all translated
transcripts since, currently, TMHMM was found to be the
best-performing TM prediction program [39]. The TM
domain location was mapped to the exon structure and we
considered a TM helix as encoded by two exons if each exon
encoded at least 25% of the domain.
Glycosylation and phosphorylation contexts
We used Phospho.ELM version 2.0 and O-GlycBase v6.00.
The SwissProt IDs were converted to RefSeq IDs with the
table from the HUGO gene nomenclature committee website
[40]. The location of the modified residues was mapped to the
exon structure and we retained those close to an exon bound-
ary (<10 amino acid distance for glycosylated and <5 amino
acid distance for phosphorylated residues). To compute the
scores for the glycosylated serine, we used NetOGlyc 2.0
because the latest version (3.1) is not able to recognize the ser-
ine in the annotated context.
Pfam domains
Pfam domains were found with hmmpfam using the 'gather-
ing cutoff' scores as given in the Pfam database (version 14).
We considered domains with less than 200 residues that are
encoded by two or more exons (each exon encodes at least two
residues of the Pfam). Additionally, we used the algorithm
described in [24] to find cases where the RefSeq transcript is
the longer splice form and a shorter exon skipping variant
exists that encodes a new Pfam domain. To confirm such can-
didate splice forms, we searched dbEST with BLAST and the
40-nucleotide context from the up- and downstream exon.
Test of Pfam domain creation by chance
We compiled a set of 10,962 internal coding exons with a size
divisible by three that had at least six ESTs showing their
inclusion but no EST indicating their skipping. Those exons
were considered to be constitutive. We produced the full-
length protein and the shorter protein that corresponds to the
hypothetical splice form without such an exon. Then, we used
hmmpfam with the gathering cut-offs to search the Pfam
database and compared the Pfam family hits for the full-
length and the shorter protein.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a table listing the
TM domains that are encoded by two exons. Additional data
file 2 contains the number of ESTs/RefSeqs and information
about the tissues or libraries for both splice variants of the
examples. Additional data file 3 contains the four cases where
skipping of a constitutive exon results in a new Pfam domain.
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